Vaginal medical device is effective against infections and vaginal dryness Vulvovaginal infections caused by Candida albicans are among the leading causes of intimate discomfort in women, with recurring symptoms such as itching, burning, leucorrhoea, and pain during intercourse. They affect women of all ages and may occur even in the absence of evident risk factors.…
Medical device with hyaluronic acid and natural actives to relieve dryness, itching, irritation, and intimate infections We are proud to announce that our vaginal ovule, a Class IIa medical device, has been officially registered with the Cabinet of Ministers of Ukraine. This milestone confirms the safety and effectiveness of our formula, developed to meet the…
Medical device based on 3% Boric Acid for the treatment of vaginal infections and dryness: results after 4 weeks of treatment Vaginal infections, particularly those caused by Candida albicans, represent one of the main causes of intimate discomfort in women, with recurrent episodes that significantly affect daily well-being and quality of life. To meet this…
MDD Certified Vaginal Tablets for Intimate Health The Medical Device Regulation (MDR), in effect since May 2017 and fully applicable from May 2021, regulates medical devices in Europe. Thanks to deadline extensions, devices compliant with the MDD Directive can continue to be marketed until December 31, 2027, for Class III and implantable Class IIb devices,…
MDD Certification for Our Vaginal Ovules: A New Milestone for Intimate Health The MDR Regulation, in force since May 2017 and applicable from May 2021, governs European medical devices. Deadline extensions allow medical devices compliant with the Medical Device Directive (MDD) to be marketed until December 31, 2027, for Class III and implantable Class IIb…